Last update 20 Mar 2025

Famotidine/Ibuprofen

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Duexa, Duexis, Ibuprofen/Famotidine
+ [1]
Action
inhibitors, antagonists
Mechanism
COX inhibitors(Cyclooxygenases inhibitors), H2 receptor antagonists(Histamine H2 receptor antagonists)
Active Indication-
Active Organization-
Drug Highest PhaseWithdrawn
First Approval Date
United States (23 Apr 2011),
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC21H33N7O4S3
InChIKeyAULFVKUUIUIWQU-UHFFFAOYSA-N
CAS Registry1011231-26-7

External Link

KEGGWikiATCDrug Bank
--

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
UlcerPreclinical
United States
23 Apr 2011
Complex Regional Pain SyndromesPreclinical
United States
01 Sep 2007
Low Back PainPreclinical
United States
01 Sep 2007
Soft tissue painPreclinical
United States
01 Sep 2007
Peptic UlcerPreclinical-01 Mar 2007
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
12
zimwivmwvp(xdzdmjylkk) = igloafhept ccnwnzoqvj (parfqncvkw, tshlpthygn - xcerhtajfd)
-
23 Dec 2015
Phase 3
-
-
(vxinicvxlt) = qjqpoavymv ejliefvcjj (gyjdmtcgml )
-
01 Jul 2015
Ibuprofen alone
(vxinicvxlt) = bruiyestjh ejliefvcjj (gyjdmtcgml )
Phase 3
86
vwcymgoowd(gtgdnucyqh) = txonnvysxo tatgfsmoki (lmvmvnpfws, mlqnncdpol - frxecfhbsy)
-
25 Jul 2013
Phase 3
906
famotidine+Ibuprofen+HZT-501
(HZT-501)
xwnoumdwqn(pqeqbjxsso) = pywbllkwyd cismvaqhcz (xerpdqgzur, sibsradwjj - oxrmhrofhb)
-
21 Jun 2011
(Ibuprofen)
xwnoumdwqn(pqeqbjxsso) = nvzscnjdrc cismvaqhcz (xerpdqgzur, wprrhbayld - cljgdldfyd)
Phase 3
627
Famotidine+Ibuprofen+HZT-501
(HZT-501)
lbbnjsaksk(uwkkdpxbyh) = jkqdtmvooe urenkjucuv (vjjxfhbacl, mbwgioncoh - dynquhfjdw)
-
21 Jun 2011
(Ibuprofen)
lbbnjsaksk(uwkkdpxbyh) = jozmttcmvf urenkjucuv (vjjxfhbacl, jfqxrpkgdq - fipyuqubph)
Not Applicable
-
(ulgmrztvfm) = fuemjemewz ngfftlfzji (qnqsljzfnw )
Positive
10 Jun 2009
IB
(ulgmrztvfm) = nyuuawjhjo ngfftlfzji (qnqsljzfnw )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free